Paper42578286
Dual inhibition of SGLT 1 and 2 by sotagliflozin alleviates intracellular sodium overload and improves cardiometabolic remodelling in uraemic cardiomyopathy.
Young M and 22 others. Cardiovasc Res, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Dual inhibition of SGLT 1 and 2 by sotagliflozin alleviates intracellular sodium overload and improves cardiometabolic remodelling in uraemic cardiomyopathy. Papers, record 42578286. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42578286
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Dual inhibition of SGLT 1 and 2 by sotagliflozin alleviates intracellular sodium overload and improves cardiometabolic remodelling in uraemic cardiomyopathy.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Sodium-Glucose Transporter 1 | Major topic |
| Sodium-Glucose Transporter 2 Inhibitors | Major topic |
| Cardiomyopathies | Major topic |
| Sodium-Glucose Transporter 2 | Major topic |
| Ventricular Remodeling | Major topic |
| Sodium | Major topic |
| Energy Metabolism | Major topic |
| Myocardium | Major topic |
| Uremia | Major topic |
| Ventricular Function, Left | Major topic |
| Renal Insufficiency, Chronic | Major topic |
| Glycosides | Major topic |
| Myocytes, Cardiac | Major topic |
| Animals | |
| Male | |
| Rats, Wistar | |
| Disease Models, Animal | |
| Isolated Heart Preparation | |
| Pyrans |
Source PubMed
Grants32
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 221604/Z/20/Z | Wellcome Trust | United Kingdom | PubMed | PubMed | |
| ref.202767/Z/16/Z | British Heart Foundation | United Kingdom | PubMed | PubMed | |
| St Thomas' NHS Foundation Trust | PubMed | PubMed | |||
| RE/18/2/34213 | BHF Centre of Research Excellence | PubMed | PubMed | ||
| AIRC-MFAG 21903 | Fondation ARC pour la Recherche sur le Cancer | PubMed | PubMed | ||
| CA22169 | COST Action EU-METAHEART | PubMed | PubMed | ||
| Queen Mary University of London | PubMed | PubMed | |||
| ARCLEADER2022020004901 | Fondation ARC pour la Recherche sur le Cancer | PubMed | PubMed | ||
| G-002145 | Barts Metabolism Network | PubMed | PubMed | ||
| Barts Charity | PubMed | PubMed | |||
| 0016113 | EPSRC Impact Acceleration Account Technology | PubMed | PubMed | ||
| MRC Mouse Biochem Lab | PubMed | PubMed | |||
| MC_UU_00014/5 | Medical Research Council | United Kingdom | PubMed | PubMed | |
| COST | PubMed | PubMed | |||
| King's College London | PubMed | PubMed | |||
| COG 2018 - 819600_FIRM | European Research Council | International | PubMed | PubMed | |
| R01 HL177461 | NHLBI NIH HHS | United States | R01HL177461 | PubMed | NIH RePORTER |
| NIHR Biomedical Research Centre at Guy's | PubMed | PubMed | |||
| PRIN-2022 Prot. 202252ZLSX | MIUR | PubMed | PubMed | ||
| R39207/CN063 | Oxford-Bristol Myers Squibb Fellowship | PubMed | PubMed |
References80
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19509029 | SGLT1 is a novel cardiac glucose transporter that is perturbed in disease states. | Cardiovasc Res | 2009 | https://conductscience.org/library/papers/19509029 | PubMed |
| 2 | 10831630 | L-type calcium current of isolated rat cardiac myocytes in experimental uraemia. | Nephrol Dial Transplant | 2000 | https://conductscience.org/library/papers/10831630 | PubMed |
| 3 | 41272152 | Altered systemic bioenergetic reserve in chronic kidney disease predisposes hearts to worse functional outcomes. | Sci Rep | 2025 | https://conductscience.org/library/papers/41272152 | PubMed |
| 4 | 25795215 | Increasing Pyruvate Dehydrogenase Flux as a Treatment for Diabetic Cardiomyopathy: A Combined 13C Hyperpolarized Magnetic Resonance and Echocardiography Study. | Diabetes | 2015 | https://conductscience.org/library/papers/25795215 | PubMed |
| 5 | 33200891 | Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease. | N Engl J Med | 2021 | https://conductscience.org/library/papers/33200891 | PubMed |
| 6 | 12650866 | [Na+]i handling in the failing human heart. | Cardiovasc Res | 2003 | https://conductscience.org/library/papers/12650866 | PubMed |
| 7 | 32360273 | Amelioration of diastolic dysfunction by dapagliflozin in a non-diabetic model involves coronary endothelium. | Pharmacol Res | 2020 | https://conductscience.org/library/papers/32360273 | PubMed |
| 8 | 33792689 | Sodium-glucose co-transporter 2 inhibitor empagliflozin inhibits the cardiac Na+/H+ exchanger 1: persistent inhibition under various experimental conditions. | Cardiovasc Res | 2021 | https://conductscience.org/library/papers/33792689 | PubMed |
| 9 | 25351341 | Dapagliflozin reduces the amplitude of shortening and Ca(2+) transient in ventricular myocytes from streptozotocin-induced diabetic rats. | Mol Cell Biochem | 2015 | https://conductscience.org/library/papers/25351341 | PubMed |
| 10 | 26956194 | Mitonuclear communication in homeostasis and stress. | Nat Rev Mol Cell Biol | 2016 | https://conductscience.org/library/papers/26956194 | PubMed |
| 11 | 40307912 | Cytochrome P450 2E1 aggravates DXR-induced myocardial injury through imbalanced mitochondrial OPA1. | Cell Commun Signal | 2025 | https://conductscience.org/library/papers/40307912 | PubMed |
| 12 | 19213964 | Regulation of intracellular and mitochondrial sodium in health and disease. | Circ Res | 2009 | https://conductscience.org/library/papers/19213964 | PubMed |
| 13 | 36607801 | New cardiac targets for empagliflozin: O-GlcNAcylation, CaMKII, and calcium handling. | Am J Physiol Heart Circ Physiol | 2023 | https://conductscience.org/library/papers/36607801 | PubMed |
| 14 | 38769288 | Elevated Na is a dynamic and reversible modulator of mitochondrial metabolism in the heart. | Nat Commun | 2024 | https://conductscience.org/library/papers/38769288 | PubMed |
| 15 | 24227677 | featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. | Bioinformatics | 2014 | https://conductscience.org/library/papers/24227677 | PubMed |
| 16 | 38326440 | Iron deficiency and supplementation in heart failure. | Nat Rev Cardiol | 2024 | https://conductscience.org/library/papers/38326440 | PubMed |
| 17 | 37495507 | Ionic current changes underlying action potential repolarization responses to physiological pacing and adrenergic stimulation in adult rat ventricular myocytes. | Physiol Rep | 2023 | https://conductscience.org/library/papers/37495507 | PubMed |
| 18 | 40544170 | Mechano-energetic uncoupling in heart failure. | Nat Rev Cardiol | 2025 | https://conductscience.org/library/papers/40544170 | PubMed |
| 19 | 26316524 | Intracellular Na+ Concentration ([Na+]i) Is Elevated in Diabetic Hearts Due to Enhanced Na+-Glucose Cotransport. | J Am Heart Assoc | 2015 | https://conductscience.org/library/papers/26316524 | PubMed |
| 20 | 24695404 | Trimmomatic: a flexible trimmer for Illumina sequence data. | Bioinformatics | 2014 | https://conductscience.org/library/papers/24695404 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42578286
GET https://conductscience.org/api/papers/v1/42578286/authors?page=2